Print

Merck & Co., Inc. (MRK) Needs a Major Restructuring: Leerink Swann and Company Analyst Reveals  
8/21/2013 7:11:49 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two months ago, newly installed Merck R&D chief Roger Perlmutter eliminated various senior management roles and hinted further changes are in the offing in hopes of jumpstarting the unit. This was only the latest instance, though, in which the big drugmaker has reorganized to prove its mettle to Wall Street. In 2011, Merck began chopping up to 13,000 jobs in order to save up to $1.5 billion by 2015, and that came on top of previously announced cuts.

Click here to see Leerink Swann's report.

Help employers find you! Check out all the jobs and post your resume.

//-->